The "StaRRS: Statins for Risk Reduction in surgery" trial found a protective effect from cardiovascular complications in the sub-group of peripheral vascular surgery OR 0.52.
El estudio retrospectivo Statinsfor Risfe Reduction in Surgery StaRRS encontró un efecto protector de complicaciones cardiovasculares en el subgrupo de cirugía vascular periférica OR, 0,52.